Navigation Links
Regenstrief releasing new version of lingua franca needed for electronic health info exchange
Date:6/3/2010

h information exchange. The researcher clinicians found they could receive data from various INPC member institutions but that the clinical content was difficult to interpret because each used a different code for the same test or observation so it was like receiving messages in French, Spanish and Italian when all they could understand was English.

They decided to develop a lingua franca and LOINC was born. From the beginning it has been a free and open system, encouraging additions, comments and feedback. Two new versions of LOINC are issued annually, with more than 2,000 new terms for tests or clinical observations per release. These new additions are based on requests from end users.

Over the past seven years, more than 130 health-care organizations around the world, including the Centers for Disease Control, the U.S. departments of defense and veterans affairs and individual hospitals have made submissions. In the past two years, users from 131 different countries downloaded the standard more than 23,000 times. LOINC encourages and supports translation of terms and documentation into foreign languages. Currently, portions of the database have been translated into Simplified Chinese, Spanish, French, and Italian and both German and Estonian versions of the documentation also exist.

"With support from the U.S. government and other organizations, the Regenstrief Institute continues to develop LOINC as an open, freely available standard. LOINC's growing worldwide adoption is a testament to both the need for a common language and the success of this open approach," said Dr. Vreeman.


'/>"/>

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-274-7722
Indiana University School of Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Measuring success: Regenstrief helps assess value of investment in health info tech
2. RXplore: New Regenstrief tool lets docs instantly track down drug reactions
3. Regenstrief Institute to help improve disability determination through health information technology
4. Nitric oxide-releasing wrap for donor organs and cloth for therapeutic socks
5. pzizz Technology Limited Releases New “Lite” Version of the pzizz Sleep App
6. Caldwell Hospice Upgrades to Latest Version of CellTrak
7. Premier Literacy Releases Version 12 of the Most Comprehensive Offering of Literacy Tools Available Today
8. Atmail Releases Atmail Messaging Software Version 6.1.7
9. ELLKAY Launches Electronic Medical Records (EMR) Conversion Division to Healthcare Industry
10. CEMPER.COM Launches New Link Research Tool Version with New Data Source Support for SeoMoz, Sistrix, SEMrush and Majestic SEO
11. buySAFE, Inc. Releases a Breakthrough White Paper that is a Must Read for Every Internet Retailer Interested in Increasing Website Conversion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2015)... Orion, Clarkston, Metamora, Michigan (PRWEB) May 03, 2015 ... 2,000 ‘Like’ mark on their Facebook page. ... the patients on the many services the Practice has, ... as current events. , Women’s Excellence has a very ... Google +, Pinterest, Instagram and You Tube. , ...
(Date:5/3/2015)... “ BolehVPN ” was featured on NewsWatch ... latest and coolest technology products available to consumers. Scott Steinberg, ... review and shared with viewers how to protect their private ... is on computers and even more so online. It helps ... all over the world. In terms of work, the internet ...
(Date:5/3/2015)... HealthPostures, a pioneering ergonomics company that ... the , May 5 - 7, 2015 Minnesota Safety ... the conference include its bestselling TaskMate sit stand solutions. ... 6100 TaskMate Executive. Features of the 6100 TaskMate Executive ... extended platform work surface and supply holders. Weighing 50 ...
(Date:5/2/2015)... Viejo, CA (PRWEB) May 02, 2015 ProText ... exclusively for use in Final Cut Pro X. ProText ... for use in Final Cut Pro X . ... single keyframe with Pixel Film Studios' ProText Kinetic 2. , ... Start by staggering two ProText Kinetic presets in the ...
(Date:5/2/2015)... Kare Visits LLC. launched in Chicago in response to ... Visits offers relief for caregivers by visiting loved ones in ... to the Caregiver Action Network, eight in ten caregivers are ... week caring for an elderly or disabled loved one. ... a caregiver is now empowered to schedule an on demand ...
Breaking Medicine News(10 mins):Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2
... and colleagues has found that angioplasty-the most common procedure ... thousands of tiny particles into the bloodstream that can ... data in humans to show that debris released during ... harmful to kidney function, said Matthew Edwards, M.D., M.S., ...
... revealed that individuals with autism spectrum ... and Asperger's syndrome can be trained to understand the ... ,UCLA researchers have shown that ASD children can be ... and tone of voice elicited an increased response in ...
... virus, which is potentially lethal to humans, had been found in ... birds in Germany. ,The presence of H5N1 bird flu ... just four kilometers (2.5 miles) from a farm where some 6,000 ... ,The farm in Tisova was the first incidence of ...
... has approved a loan of 80 million dollars (60 million ... a major challenge in the country, an official statement ... strengthen the National AIDS Control Council (NACC), the country's frontline ... least 1.5 million people since 1984. ,"We are ...
... down for a nap in the afternoon may give you a ... researchers are warning that it could prove harmful for your kids. ... the University of Florida led by Dr Joe McNamara concluding that ... ,They found that snoozing at this time may prevent kids from ...
... Moving closer to solving Lou Gehrig's disease mystery, UCLA, ... a protein that plays a key role in ... known as Lou Gehrig's disease, a progressive, fatal neuro-degenerative ... Valentine, UCLA professor of chemistry and biochemistry, has studied ...
Cached Medicine News:Health News:Angioplasty may Damage Kidneys 2Health News:Angioplasty may Damage Kidneys 3Health News:Autistic Individuals can Be 'trained' to Comprehend Visual and Vocal Cues 2Health News:Potentially Lethal H5N1 Bird Flu Resurfaces in Europe 2Health News:Boffins a Step Closer to Solving Puzzle of Lou Gehrig's Disease 2Health News:Boffins a Step Closer to Solving Puzzle of Lou Gehrig's Disease 3
(Date:5/1/2015)... Intarcia Therapeutics, Inc. today announced the appointment of ... Resources, reporting directly to Kurt Graves , Intarcia,s ... of the senior leadership team, Mr. Brady will work ... the Company advances its business, brings in and retains ... its dynamic culture. Another essential goal for Mr. Brady ...
(Date:5/1/2015)... LITTLE FALLS, N.J. , May 1, 2015 ... Andrew A. Krakauer , Chief Executive Officer, will be ... Conference at the Encore at the Wynn in ... for Thursday, May 14, 2015 at 10:00 AM PT/1:00 PM ... meetings during the day. An audio webcast ...
(Date:5/1/2015)... 2015  Portal Instruments, Inc., an emerging leader in ... that Robert Langer, Sc. D., MIT Institute Professor, ... Distinguished Professor have joined the company,s Scientific Advisory Board. ... biotechnology leaders, Professor Robert Langer and Professor ... Patrick Anquetil , Chief Executive Officer of Portal ...
Breaking Medicine Technology:Intarcia Appoints James P. Brady Vice President, Human Resources 2Intarcia Appoints James P. Brady Vice President, Human Resources 3Intarcia Appoints James P. Brady Vice President, Human Resources 4Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 2Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 3Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 4
... study ever to examine the preventive use of blood-thinning ... with cancer undergoing chemotherapy will be presented in a ... during the 50th Annual Meeting of the American Society ... featured at the press conference includes studies that examine ...
... Daiichi Sankyo,Company, Limited (TSE: 4568), announced today that it ... investigational oral Factor Xa,inhibitor, in patients with atrial fibrillation. ... The Phase III ... Atrial Fibrillation (ENGAGE-AF TIMI 48), will compare DU-176b,with warfarin ...
Cached Medicine Technology:Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 2Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 3Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 4Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 5Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 6Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 7Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 8Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 9Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 2Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 3Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: